190 related articles for article (PubMed ID: 25569645)
1. Markers of cardiac dysfunction in cognitive impairment and dementia.
Hilal S; Chai YL; Ikram MK; Elangovan S; Yeow TB; Xin X; Chong JY; Venketasubramanian N; Richards AM; Chong JPC; Lai MKP; Chen C
Medicine (Baltimore); 2015 Jan; 94(1):e297. PubMed ID: 25569645
[TBL] [Abstract][Full Text] [Related]
2. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia.
Chai YL; Hilal S; Chong JPC; Ng YX; Liew OW; Xu X; Ikram MK; Venketasubramanian N; Richards AM; Lai MKP; Chen CP
Medicine (Baltimore); 2016 Aug; 95(33):e4566. PubMed ID: 27537582
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
5. Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts.
Hilal S; Chai YL; van Veluw S; Shaik MA; Ikram MK; Venketasubramanian N; Richards AM; Biessels GJ; Chen C
JAMA Neurol; 2017 Apr; 74(4):403-410. PubMed ID: 28166312
[TBL] [Abstract][Full Text] [Related]
6. Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment.
Chai YL; Chong JR; Raquib AR; Xu X; Hilal S; Venketasubramanian N; Tan BY; Kumar AP; Sethi G; Chen CP; Lai MKP
Sci Rep; 2021 Feb; 11(1):4010. PubMed ID: 33597603
[TBL] [Abstract][Full Text] [Related]
7. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.
Gyanwali B; Shaik MA; Venketasubramanian N; Chen C; Hilal S
J Alzheimers Dis; 2019; 71(4):1309-1320. PubMed ID: 31524167
[TBL] [Abstract][Full Text] [Related]
8. Cross-Sectional Associations Between Cardiac Biomarkers, Cognitive Performance, and Structural Brain Changes Are Modified by Age.
Veugen MGJ; Henry RMA; Brunner-La Rocca HP; Dagnelie PC; Schram MT; van Agtmaal MJM; van der Kallen CJH; Sep SJS; van Boxtel MPJ; Bekers O; Meex SJR; Jansen JFA; Kroon AA; Stehouwer CDA
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1948-1958. PubMed ID: 29954754
[TBL] [Abstract][Full Text] [Related]
9. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
[TBL] [Abstract][Full Text] [Related]
10. Associations of Blood Cardiovascular Biomarkers With Brain Free Water and Its Relationship to Cognitive Decline: A Diffusion-MRI Study.
Ji F; Chai YL; Liu S; Kan CN; Ong M; Richards AM; Tan BY; Venketasubramanian N; Pasternak O; Chen C; Lai MKP; Zhou JH
Neurology; 2023 Jul; 101(2):e151-e163. PubMed ID: 37202157
[TBL] [Abstract][Full Text] [Related]
11. Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia.
Wu LY; Cheah IK; Chong JR; Chai YL; Tan JY; Hilal S; Vrooman H; Chen CP; Halliwell B; Lai MKP
Free Radic Biol Med; 2021 Dec; 177():201-211. PubMed ID: 34673145
[TBL] [Abstract][Full Text] [Related]
12. Global cerebrovascular burden and long-term clinical outcomes in Asian elderly across the spectrum of cognitive impairment.
Xu X; Chan YH; Chan QL; Gyanwali B; Hilal S; Tan BY; Ikram MK; Venketasubramanian N; Chen CL
Int Psychogeriatr; 2018 Sep; 30(9):1355-1363. PubMed ID: 29665875
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
14. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.
Xu X; Phua A; Collinson SL; Hilal S; Ikram MK; Wong TY; Cheng CY; Venketasubramanian N; Chen C
Stroke Vasc Neurol; 2019 Sep; 4(3):135-140. PubMed ID: 31709119
[TBL] [Abstract][Full Text] [Related]
16. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
17. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
[TBL] [Abstract][Full Text] [Related]
18. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
